|
業務類別
|
-- |
|
業務概覽
|
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment. |
| 公司地址
| 2701 Kent Avenue, West Lafayette, IN, USA, 47906 |
| 電話號碼
| +1 765 463-4527 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.inotivco.com |
| 員工數量
| 2046 |
| Mr. Jeffrey Arthur Krupp |
Senior Vice President, Human Resources |
-- |
05/12/2025 |
| Mr. Brennan Freeman |
Vice President, Finance, Corporate Controller and Principal Accounting Officer |
-- |
05/12/2025 |
| Mr. Michael Garrett |
Chief Commercial Officer |
-- |
12/12/2023 |
| Dr. Adrian Hardy, PhD |
Executive Vice President |
-- |
05/12/2025 |
| Mr. Robert W. Leasure, Jr |
Director, President and Chief Executive Officer |
美元 800.00K |
05/12/2025 |
| Mr. John Gregory Beattie |
Chief Operating Officer |
-- |
05/12/2025 |
| Mr. William D. Pitchford |
Chief Human Resources Officer |
-- |
13/01/2023 |
| Mr. James Harkness |
Chief Operating Officer, Research Models and Services |
-- |
24/06/2022 |
| Dr. John E. Sagartz, D.V.M.,PhD |
Director and Chief Strategy Officer |
美元 400.00K |
05/12/2025 |
| Ms. Fernanda Beraldi |
General Counsel and Corporate Secretary |
-- |
13/01/2023 |
| Ms. Andrea Castetter |
General Counsel, Corporate Secretary and Chief Compliance Officer |
-- |
05/12/2025 |
| Mr. Philip A. Downing |
Senior Vice President, Preclinical Services |
-- |
21/12/2021 |
| Ms. Beth A. Taylor |
Executive Vice President and Chief Financial Officer |
美元 410.00K |
05/12/2025 |
| Mr. Mark Bibi |
General Counsel and Secretary |
-- |
21/12/2021 |
|
|
| Mr. David Landman |
Independent Director |
05/12/2025 |
| Ms. Terry Coelho |
Independent Director |
05/12/2025 |
| Mr. Eugene Davis |
Independent Director |
18/05/2026 |
| Mr. R. Matthew Neff |
Chairman of The Board |
05/12/2025 |
| Mr. Robert W. Leasure, Jr |
Director, President and Chief Executive Officer |
05/12/2025 |
| Ms. Terry Coelho |
Director |
19/10/2023 |
| Dr. Gregory C. Davis, PhD |
Chairman of the Board |
26/01/2024 |
| Mr. Scott Cragg |
Director |
05/11/2021 |
| Dr. Nigel Brown, PhD |
Independent Director |
05/12/2025 |
| Dr. John E. Sagartz, D.V.M.,PhD |
Director and Chief Strategy Officer |
05/12/2025 |
| Mr. John T. Young |
Independent Director |
18/05/2026 |
| Mr. Richard Allen Johnson, PhD |
Independent Director |
05/11/2021 |
| Mr. Michael J. Harrington |
Independent Director |
05/12/2025 |
|
|
|
|
